Use of substances binding to GSTM for the diagnosis and treatment of bladder cancer
DE10300861A1
Use of substances that bind to FABP4 for the diagnosis and treatment of bladder cancer
DE10259619A1
Use of a TRPM8 activating substance for tumor treatment
DE10258051A1
Use of substances that bind to HAT for the diagnosis and treatment of squamous cell carcinoma of the lungs
US2003105315A1
Human nucleic acid sequences from ovarian tumor tissue
DE10234901A1
New nucleic acids encoding Mrp4, useful in the diagnosis of prostatic, bladder and ovarian tumors, also in screening for specific binding agents, and potential therapeutic agents
DE10230631A1
Uses of Ngal-binding substances for the diagnosis and treatment of cancer
DE10225180A1
Protein or peptide (MIMPD), nucleic acid coding therefor and uses of these substances
DE10223246A1
Slit1 and MEGF4 isoforms and their use
DE10215321A1
New nucleic acid encoding Trpp8 splice variants, useful for diagnosis of prostatic cancer, and to screen for diagnostic or therapeutic agents, also related proteins
DE10215320A1
Diagnosis of uterine or ovarian cancer, by detecting overexpression of TFF3 protein or nucleic acid, also treatment using TTF3 inhibitors
DE10159215A1
Use of a KMO inhibitor for the manufacture of a pharmaceutical composition
DE10004102A1
Nucleic acids differentially expressed between tumor and normal cells, useful for diagnosis or therapy of tumors and for screening active agents
